Literature DB >> 35273738

Effect of continuity of care on quality of life and medication compliance of patients with ST-segment elevation myocardial infarction.

Li Zhang1, Guixia Niu2, Guiqin Zhang3.   

Abstract

OBJECTIVE: To investigate the effects of continuity of care (COC) on the quality of life and medication compliance of patients with ST-segment elevation myocardial infarction (STEMI).
METHODS: A retrospective analysis was conducted in 98 patients with STEMI that were treated in our hospital from January 2017 to December 2018. The 98 cases were assigned to a control group given routine nursing and an experimental group given routine nursing combined with COC according to different nursing approaches. The quality of life and medication compliance in the two groups were compared.
RESULTS: Higher role-emotional (RE) scores were observed in the control group after nursing (P<0.05). Compared to results before nursing as well as the control group, the experimental group obtained higher quality of life scores in the dimensions of physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), RE, mental health (MH), and better medication compliance after the implementation of COC (P<0.05). Compared to the control group, the experimental group showed a markedly lower incidence of minor bleeding and arrhythmia, a higher nursing satisfaction, and a higher excellent and good rate of cardiac function (P<0.05). The experimental group outperformed the control group in left ventricular ejection fraction (LVEF) and 6-min walking distance (P<0.05).
CONCLUSION: COC improves the quality of life, medication compliance, and nursing satisfaction of STEMI patients, and reduces adverse events. AJTR
Copyright © 2022.

Entities:  

Keywords:  Continuity of care; ST-segment elevation myocardial infarction; medication compliance; quality of life

Year:  2022        PMID: 35273738      PMCID: PMC8902574     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  19 in total

1.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

2.  First outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting.

Authors:  Siren Rettedal; Iren H Löhr; Olav Natås; Christian G Giske; Arnfinn Sundsfjord; Knut Øymar
Journal:  APMIS       Date:  2012-03-24       Impact factor: 3.205

3.  Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy).

Authors:  Nobuaki Kobayashi; Akiko Maehara; Gary S Mintz; Steven D Wolff; Philippe Généreux; Ke Xu; Roxana Mehran; C Michael Gibson; Sorin J Brener; Gregg W Stone
Journal:  Am J Cardiol       Date:  2015-02-19       Impact factor: 2.778

4.  Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial.

Authors:  Gennaro Giustino; Björn Redfors; Sorin J Brener; Ajay J Kirtane; Philippe Généreux; Akiko Maehara; Dariusz Dudek; Thomas Neunteufl; D Christopher Metzger; Aaron Crowley; Roxana Mehran; C Michael Gibson; Gregg W Stone
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2017-08-22

Review 5.  Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis.

Authors:  Jorge Sanz-Sánchez; Mauro Chiarito; Damiano Regazzoli; Francesco Cannata; Gianluigi Condorelli; Bernhard Reimers; Giulio G Stefanini
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2020-12       Impact factor: 2.160

6.  Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study.

Authors:  Sameer Arora; Kunihiro Matsushita; Arman Qamar; R Brandon Stacey; Melissa C Caughey
Journal:  Catheter Cardiovasc Interv       Date:  2017-06-01       Impact factor: 2.692

Review 7.  Extended nurse prescribing: improving care for older people.

Authors:  Jane Astles
Journal:  Br J Nurs       Date:  2006 Feb 9-22

8.  Does Timing of Coronary Artery Bypass Surgery Affect Early and Long-Term Outcomes in Patients With Non-ST-Segment-Elevation Myocardial Infarction?

Authors:  Piroze M Davierwala; Alexander Verevkin; Sergey Leontyev; Martin Misfeld; Michael A Borger; Friedrich W Mohr
Journal:  Circulation       Date:  2015-08-25       Impact factor: 29.690

9.  Usefulness of Extended-FAST (EFAST-Extended Focused Assessment with Sonography for Trauma) in critical care setting.

Authors:  Uri Adrian Prync Flato; Hélio Penna Guimarães; Renato Delascio Lopes; Jorge Luís Valiatti; Elias Marcos Silva Flato; Ricardo Gonçalves Lorenzo
Journal:  Rev Bras Ter Intensiva       Date:  2010-09

10.  Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.

Authors:  Faustine Ndugulile; Roland Jureen; Stig Harthug; Willy Urassa; Nina Langeland
Journal:  BMC Infect Dis       Date:  2005-10-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.